131 related articles for article (PubMed ID: 15280599)
1. Production of antibodies against degradative neoepitopes in aggrecan.
Mort JS; Roughley PJ
Methods Mol Med; 2004; 100():237-50. PubMed ID: 15280599
[TBL] [Abstract][Full Text] [Related]
2. Neoepitope antibodies against MMP-cleaved and aggrecanase-cleaved aggrecan.
Fosang AJ; Last K; Stanton H; Golub SB; Little CB; Brown L; Jackson DC
Methods Mol Biol; 2010; 622():312-47. PubMed ID: 20135291
[TBL] [Abstract][Full Text] [Related]
3. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis.
Buzás EI; Végvári A; Murad YM; Finnegan A; Mikecz K; Glant TT
Cell Immunol; 2005 Jun; 235(2):98-108. PubMed ID: 16185673
[TBL] [Abstract][Full Text] [Related]
4. Human cartilage aggrecan CS1 region contains cryptic T-cell recognition sites.
Goodacre JA; Middleton S; Lynn S; Ross DA; Pearson J
Immunology; 1993 Apr; 78(4):586-91. PubMed ID: 8388364
[TBL] [Abstract][Full Text] [Related]
5. Use of an antibody against the matrix metalloproteinase-generated aggrecan neoepitope FVDIPEN-COOH to assess the effects of stromelysin in a rabbit model of cartilage degradation.
Bayne EK; MacNaul KL; Donatelli SA; Christen A; Griffin PR; Hoerrner LA; Calaycay JR; Ayala JM; Chapman K; Hagmann W
Arthritis Rheum; 1995 Oct; 38(10):1400-9. PubMed ID: 7575690
[TBL] [Abstract][Full Text] [Related]
6. Antibodies to MMP-cleaved aggrecan.
Fosang AJ; Last K; Jackson DC; Brown L
Methods Mol Biol; 2001; 151():425-49. PubMed ID: 11217318
[No Abstract] [Full Text] [Related]
7. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
8. Identification of fibronectin neoepitopes present in human osteoarthritic cartilage.
Zack MD; Arner EC; Anglin CP; Alston JT; Malfait AM; Tortorella MD
Arthritis Rheum; 2006 Sep; 54(9):2912-22. PubMed ID: 16948117
[TBL] [Abstract][Full Text] [Related]
9. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis.
Glant TT; Mikecz K
Methods Mol Med; 2004; 102():313-38. PubMed ID: 15286393
[TBL] [Abstract][Full Text] [Related]
10. [Synthesis of dominant epitopes on N-terminal part of BPI and preparation of corresponding antisera].
Chen YQ; Peng Z; Long J; Zhang GM; Lu Z; An YQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):143-5. PubMed ID: 17286909
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B: an alternative protease for the generation of an aggrecan 'metalloproteinase' cleavage neoepitope.
Mort JS; Magny MC; Lee ER
Biochem J; 1998 Nov; 335 ( Pt 3)(Pt 3):491-4. PubMed ID: 9794785
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies against aggrecan in systemic rheumatic diseases.
Vynios DH; Tsagaraki I; Grigoreas GH; Samiotaki M; Panayotou G; Kyriakopoulou D; Georgiou P; Korbakis D; Panayotou A; Nanouri K; Assouti M; Andonopoulos AP
Biochimie; 2006 Jul; 88(7):767-73. PubMed ID: 16488067
[TBL] [Abstract][Full Text] [Related]
13. Production and characterization of antipeptide kallikrein 4 antibodies. Use of computer modeling to design peptides specific to Kallikrein 4.
Harvey TJ; Dong Y; Bui L; Jarrott R; Walsh T; Clements JA
Methods Mol Med; 2003; 81():241-54. PubMed ID: 12725124
[No Abstract] [Full Text] [Related]
14. Humoral immune responses to peptides derived from the beta-amyloid peptide C-terminal sequence.
Miller DL; Potempska A; Mehta PD
Amyloid; 2007 Mar; 14(1):39-50. PubMed ID: 17453624
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the bovine aggrecan gene: genomic structure and physical and linkage mapping.
Cavanagh JA; Tammen I; Hayden MJ; Gill CA; Nicholas FW; Raadsma HW
Anim Genet; 2005 Oct; 36(5):452-4. PubMed ID: 16167996
[No Abstract] [Full Text] [Related]
16. Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region.
Kondo K; Ishii Y; Ochi H; Matsumoto T; Yoshikawa H; Kanda T
Virology; 2007 Feb; 358(2):266-72. PubMed ID: 17010405
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity of synthetic peptides derived from Plasmodium falciparum proteins.
Zerpa NC; Wide A; Noda J; Bermúdez H; Pabón R; Noya OO
Exp Parasitol; 2006 Aug; 113(4):227-34. PubMed ID: 16513113
[TBL] [Abstract][Full Text] [Related]
18. Use of anti-neoepitope antibodies for the analysis of degradative events in cartilage and the molecular basis for neoepitope specificity.
Mort JS; Flannery CR; Makkerh J; Krupa JC; Lee ER
Biochem Soc Symp; 2003; (70):107-14. PubMed ID: 14587286
[TBL] [Abstract][Full Text] [Related]
19. Production and characterization of peptide antibodies.
Trier NH; Hansen PR; Houen G
Methods; 2012 Feb; 56(2):136-44. PubMed ID: 22178691
[TBL] [Abstract][Full Text] [Related]
20. Functional reconstruction and synthetic mimicry of a conformational epitope using CLIPS technology.
Timmerman P; Puijk WC; Meloen RH
J Mol Recognit; 2007; 20(5):283-99. PubMed ID: 18074397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
